U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$88.68 USD
+0.96 (1.09%)
Updated Oct 13, 2025 03:58 PM ET
After-Market: $88.96 +0.28 (0.32%) 6:12 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, U.S. Physical Therapy, Inc. has a PEG ratio of 4.37 compared to the Medical - Outpatient and Home Healthcare industry's PEG ratio of 1.90.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
USPH 88.68 +0.96(1.09%)
Will USPH be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for USPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USPH
ELAN or USPH: Which Is the Better Value Stock Right Now?
ASTH vs. USPH: Which Stock Is the Better Value Option?
USPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
ASTH or USPH: Which Is the Better Value Stock Right Now?
Does U.S. Physical Therapy (USPH) Have the Potential to Rally 26.48% as Wall Street Analysts Expect?
U.S. Physical Therapy (USPH) Tops Q2 Earnings and Revenue Estimates
Other News for USPH
USPH forms Non-ADX 1,2,3,4 Bullish on October 10
Is USPH primed for volatility? NR7 shows up after sinking 1.68%
Is USPH building pressure? NR7 shows up after gaining 0.68%
USPH Dividend Yield Pushes Above 2%
Is USPH ready to move higher? New Uptrend shows up after rising 0.27%